Rocky Mountain Cancer Centers is United in Healing with The US Oncology Network
Rocky Mountain Cancer Centers (RMCC) is united in healing with The US Oncology Network, one of the nation’s largest networks of integrated community based oncology practices dedicated to advancing high-quality, evidence-based cancer care. As an affiliate of The US Oncology Network, RMCC is united with nearly 1,000 physicians nationwide. RMCC participates in clinical trials through US Oncology Research, which has played a role in the development of more than 70 FDA approved cancer therapies.
US Oncology Research
Supported by McKesson Specialty Health and The US Oncology Network, US Oncology Research draws from a network of experienced investigators and dedicated clinical staff who specialize in Phase I through Phase IV oncology clinical trials. US Oncology Research serves approximately 80 research sites and nearly 225 locations managing about 225 active trials at any given time. Physicians in the research network have enrolled more than 56,000 patients in nearly 1,300 trials since inception in 1992. Rocky Mountain Cancer Centers was the 2015 recipient of the Highest Accruing Site Award, having more than 1,900 patients in clinical trials.